Age differences in clinical features and outcomes in patients with COVID-19, Jiangsu, China: a retrospective, multicentre cohort study

Huanyuan Luo,Songqiao Liu,Yuancheng Wang,Penelope A Phillips-Howard,Shenghong Ju,Yi Yang,Duolao Wang
DOI: https://doi.org/10.1136/bmjopen-2020-039887
IF: 3.006
2020-10-01
BMJ Open
Abstract:Objectives To determine the age-specific clinical presentations and incidence of adverse outcomes among patients with COVID-19 in Jiangsu, China. Design and setting Retrospective, multicentre cohort study performed at 24 hospitals in Jiangsu, China. Participants 625 patients with COVID-19 enrolled between 10 January and 15 March 2020. Results Of the 625 patients (median age, 46 years; 329 (52.6%) men), 37 (5.9%) were children (18 years or younger), 261 (41.8%) young adults (19–44 years), 248 (39.7%) middle-aged adults (45–64 years) and 79 (12.6%) elderly adults (65 years or older). The incidence of hypertension, coronary heart disease, chronic obstructive pulmonary disease and diabetes comorbidities increased with age (trend test, p<0.0001, p=0.0003, p<0.0001 and p<0.0001, respectively). Fever, cough and shortness of breath occurred more commonly among older patients, especially the elderly, compared with children (χ 2 test, p = 0.0008, 0.0146 and 0.0282, respectively). The quadrant score and pulmonary opacity score increased with age (trend test, both p<0.0001). Older patients had many significantly different laboratory parameters from younger patients. Elderly patients had the highest proportion of severe or critically-ill cases (33.0%, χ 2 test p<0.0001), intensive care unit use (35.4%, χ 2 test p<0.0001), respiratory failure (31.6%, χ 2 test p<0.0001) and the longest hospital stay (median 21 days, Kruskal–Wallis test p<0.0001). Conclusions Elderly (≥65 years) patients with COVID-19 had the highest risk of severe or critical illness, intensive care use, respiratory failure and the longest hospital stay, which may be due partly to their having a higher incidence of comorbidities and poor immune responses to COVID-19.
medicine, general & internal
What problem does this paper attempt to address?
This paper aims to explore the differences in clinical characteristics and clinical outcomes of patients in different age groups after being infected with COVID - 19. Specifically, the researchers hope to determine how age affects the clinical manifestations of the disease and the incidence of adverse outcomes among COVID - 19 patients in Jiangsu province, China. Through this study, they hope to better understand age - related susceptibility and pathological mechanisms, especially in the elderly population, whose conditions are often more severe and whose prognoses are also worse. The key points of the study include: - **The relationship between age and disease severity**: The study found that as age increases, the incidence of comorbidities such as hypertension, coronary heart disease, chronic obstructive pulmonary disease, and diabetes in patients increases significantly. In addition, among the elderly population (aged 65 and above), the incidence of symptoms such as fever, cough, and dyspnea is significantly higher than that in children. - **Changes in laboratory parameters**: Multiple vital sign parameters of elderly patients at admission, such as systolic blood pressure (SBP), diastolic blood pressure (DBP), and oxygen saturation (SpO2), change linearly with age. In addition, the lung quadrant score and lung opacity score also increase with age. - **Differences in clinical outcomes**: The study also shows that the proportion of severe or critical cases is the highest among elderly patients, and the proportion of those requiring intensive care unit (ICU) treatment, the proportion of those with respiratory failure, and the length of hospital stay are also the longest. These findings emphasize the important role of age as a host factor in the susceptibility and disease severity of COVID - 19. In particular, the elderly are at higher risk due to a higher incidence of comorbidities and a poorer immune response.